Pricing Log in Create free account

NervGen Pharma Corp. (NGEN) vs Sutro Biopharma, Inc. (STRO)

NervGen Pharma Corp. and Sutro Biopharma, Inc. are both Biotechnology companies. Sutro Biopharma, Inc. is the larger, with a market value of $159.5M against $143.1M — 1.1× the size. NervGen Pharma Corp. has the higher net margin (0.00% vs −395.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, NervGen Pharma Corp. leads on 6 and Sutro Biopharma, Inc. on 4.

Valuation

Metric NGEN STRO Biotechnology median
P/E n/m n/m 10.60
P/S n/m 3.49 9.40
P/B 3.63 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 0.06 9.02
Earnings yield (17.89%) (180.08%) (32.88%)
Free cash flow yield (14.96%) (91.34%) (23.13%)

Profitability

Metric NGEN STRO Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin 0.00% (319.57%) 0.00%
Net margin 0.00% (395.25%) 0.00%
Free cash flow margin 0.00% (318.63%) 0.00%
Return on equity (94.85%) 266.76% (51.96%)
Return on assets (40.66%) (79.08%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NGEN STRO Biotechnology median
Revenue growth (TTM) — (56.25%) 6.76%
EPS growth (last fiscal year) (68.14%) 24.02% 29.88%
Revenue growth, 5-year CAGR — 19.12% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric NGEN STRO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.07 3.32 4.97
Net debt to EBITDA 0.95 0.92 1.01

Dividend

Metric NGEN STRO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NGEN STRO Biotechnology median
Market cap 143.13m 159.51m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack